The BSR-PsA : study protocol for the British Society for Rheumatology psoriatic arthritis register
| dc.contributor.author | Jones, Gareth T. | |
| dc.contributor.author | Macfarlane, Gary J. | |
| dc.contributor.author | Forrest Keenan, Karen | |
| dc.contributor.author | McNamee, Paul | |
| dc.contributor.author | Neilson, Aileen R. | |
| dc.contributor.author | Siebert, Stefan | |
| dc.contributor.author | Burden, A. David | |
| dc.contributor.author | Kay, Lesley | |
| dc.contributor.author | Helliwell, Philip S. | |
| dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Health Economics Research Unit | en |
| dc.date.accessioned | 2021-05-18T19:16:01Z | |
| dc.date.available | 2021-05-18T19:16:01Z | |
| dc.date.issued | 2021-05-17 | |
| dc.description | Acknowledgements We acknowledge contribution of BSR-PsA study staff, under the supervision of KFK: Maureen Heddle, Barry Morris, Jonathan Lock and Jane Brady. We also acknowledge the support from the Centre for Healthcare Randomised Trials (CHaRT) at the University of Aberdeen, especially Mark Forrest and Brian Taylor, for database and IT support. We would like to thank Professor Iain McInnes from the University of Glasgow, and our International Advisory Committee (Professors Merete Hetland, Oliver Fitzgerald and Philip Mease), for their comments when developing the protocol and for advice in harmonising data collection with other international studies, and the staff at the British Society for Rheumatology, in particular Alan Roach, Ross Matthews, Chris Hiley and Debbie MacDonald. Finally, we are indebted to the staff at all participating NHS trusts (details of which are available from www.abdn.ac.uk/bsr-psa) and especially the NIHR Clinical Research Network research nurses for their assistance with participant recruitment and data collection. Funding The BSR-PsA is funded by the BSR as part of its rheumatology registers portfolio and, in turn, receives funding for this from pharmaceutical companies. At the time of publication, only Amgen (previously Celgene) have contributed to the funding of the BSR-PsA. Pharmaceutical companies providing funds to BSR do not participant in the conduct or oversight of the study. However, they do receive advance notice of publications on which they are able to comment. Companies contributing to the funding of the register can request anonymised data on clinically confirmed serious adverse events and some events of special interest (e.g. pregnancy) among participants prescribed the specific bDMARD or tsDMARD agents that they manufacture. Other than this information, they do not have access to any raw data. They may, however, request specific analyses to be performed, for which a pre-specific analysis plan is discussed, and additional funds are provided. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 9 | |
| dc.format.extent | 608796 | |
| dc.identifier | 193454170 | |
| dc.identifier | 70d103e4-b61d-46bb-8e32-fcf65d749863 | |
| dc.identifier | 33993880 | |
| dc.identifier | 85105872607 | |
| dc.identifier.citation | Jones, G T, Macfarlane, G J, Forrest Keenan, K, McNamee, P, Neilson, A R, Siebert, S, Burden, A D, Kay, L & Helliwell, P S 2021, 'The BSR-PsA : study protocol for the British Society for Rheumatology psoriatic arthritis register', BMC Rheumatology, vol. 5, no. 1, 19 . https://doi.org/10.1186/s41927-021-00189-0 | en |
| dc.identifier.doi | 10.1186/s41927-021-00189-0 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 2520-1026 | |
| dc.identifier.other | Jisc: 637de0da146f4b6988fb55c6b2984d50 | |
| dc.identifier.other | publisher-id: s41927-021-00189-0 | |
| dc.identifier.other | manuscript: 189 | |
| dc.identifier.other | ORCID: /0000-0003-2322-3314/work/94083583 | |
| dc.identifier.other | ORCID: /0000-0003-0016-7591/work/94084262 | |
| dc.identifier.uri | https://hdl.handle.net/2164/16488 | |
| dc.identifier.vol | 5 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMC Rheumatology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Study Protocol | en |
| dc.subject | Clinical rheumatology | en |
| dc.subject | Psoriatic arthritis | en |
| dc.subject | Targeted therapy | en |
| dc.subject | Biologics | en |
| dc.subject | Biosimilars | en |
| dc.subject | Registry | en |
| dc.subject | Real world evidence | en |
| dc.subject | R Medicine | en |
| dc.subject | Other | en |
| dc.subject.lcc | R | en |
| dc.title | The BSR-PsA : study protocol for the British Society for Rheumatology psoriatic arthritis register | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
